JAZZ FY 2015 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$11B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.3B+13.0% YoY

Gross Profit

$1.2B92.3% margin

Operating Income

$508M38.4% margin

Net Income

$330M24.9% margin

EPS (Diluted)

$5.23

Cash Flow

Operating Cash Flow

$532M

Free Cash Flow

$496M

Stock-Based Comp.

$92M

Balance Sheet

Total Assets

$3.4B

Total Liabilities

$1.8B

Stockholders' Equity

$1.6B

Cash & Equivalents

$989M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.2B	+13.0%
Gross Profit	$1.2B	$1.1B	+15.8%
Operating Income	$508M	$196M	+159.8%
Net Income	$330M	$58M	+464.4%